Correlation Between Visa and Emcure Pharmaceuticals
Specify exactly 2 symbols:
By analyzing existing cross correlation between Visa Class A and Emcure Pharmaceuticals, you can compare the effects of market volatilities on Visa and Emcure Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Emcure Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Emcure Pharmaceuticals.
Diversification Opportunities for Visa and Emcure Pharmaceuticals
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Visa and Emcure is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Emcure Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emcure Pharmaceuticals and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Emcure Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emcure Pharmaceuticals has no effect on the direction of Visa i.e., Visa and Emcure Pharmaceuticals go up and down completely randomly.
Pair Corralation between Visa and Emcure Pharmaceuticals
Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.58 times more return on investment than Emcure Pharmaceuticals. However, Visa Class A is 1.73 times less risky than Emcure Pharmaceuticals. It trades about 0.12 of its potential returns per unit of risk. Emcure Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest 28,808 in Visa Class A on September 23, 2024 and sell it today you would earn a total of 2,963 from holding Visa Class A or generate 10.29% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 98.46% |
Values | Daily Returns |
Visa Class A vs. Emcure Pharmaceuticals
Performance |
Timeline |
Visa Class A |
Emcure Pharmaceuticals |
Visa and Emcure Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Visa and Emcure Pharmaceuticals
The main advantage of trading using opposite Visa and Emcure Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Emcure Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emcure Pharmaceuticals will offset losses from the drop in Emcure Pharmaceuticals' long position.Visa vs. American Express | Visa vs. Upstart Holdings | Visa vs. Capital One Financial | Visa vs. Ally Financial |
Emcure Pharmaceuticals vs. Akums Drugs and | Emcure Pharmaceuticals vs. Innova Captab Limited | Emcure Pharmaceuticals vs. Kingfa Science Technology | Emcure Pharmaceuticals vs. Rico Auto Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |